TP53 and osteosarcoma: The authors also showed that, in the human osteogenic sarcoma p53-null cell line SAOS-2, the inhibition of FAK, when p53 is re-expressed, resulted in cell death, suggesting that FAK was responsible for the blockade of p53-mediated apoptosis and transcriptional activity [21].